Ethallobarbital
WikiDoc Resources for Ethallobarbital |
Articles |
---|
Most recent articles on Ethallobarbital Most cited articles on Ethallobarbital |
Media |
Powerpoint slides on Ethallobarbital |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ethallobarbital at Clinical Trials.gov Trial results on Ethallobarbital Clinical Trials on Ethallobarbital at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ethallobarbital NICE Guidance on Ethallobarbital
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ethallobarbital Discussion groups on Ethallobarbital Patient Handouts on Ethallobarbital Directions to Hospitals Treating Ethallobarbital Risk calculators and risk factors for Ethallobarbital
|
Healthcare Provider Resources |
Causes & Risk Factors for Ethallobarbital |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ethallobarbital (brand names Dormin, Dumex, Dormitiv, Dorval), also known as ethallymal and 5-allyl-5-ethylbarbituric acid, is an allyl-substituted barbiturate described as a sedative/hypnotic.[1][2][3][4][5] It was first synthesized in 1927.[1]
See also
References
- ↑ 1.0 1.1 C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 51–. ISBN 978-0-412-46630-4.
- ↑ Martin Negwer (1978). Organic-chemical drugs and their synonyms: an international survey. Akademie-Verlag. ISBN 978-0-89573-100-5.
- ↑ Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 1440–. ISBN 978-3-7692-2114-5.
- ↑ Alberto Frigerio; Malcolm McCamish (1980). Recent Developments in Mass Spectrometry in Biochemistry and Medicine. Elsevier Scientific Publishing Company.
- ↑ GOLDHAHN H, BARTH H (November 1953). "[Barbituric acids. II]". Pharmazie. 8 (11): 913–8. PMID 13133697.